1. FDA clears LifeSignal’s wireless ECG
LifeSignals announced in a July 26 press releasethat it has received FDA clearance for its wireless LP1100 Life Signal Patch. The patch is designed to be used in wearables and healthcare monitoring devices. The clearance allows the company to use the Life Signal Processor to develop ECG and other vital sign monitoring wearables with wireless connection to the cloud. It also gives OEMs a biosensor patch for companies that are looking to deliver certain health applications in a low acuity patient monitoring space, consumer wellness, senior care and animal health.
2. DoseOptics launches radiotherapy beam imaging system
DoseOptics has launched its radiation beam imaging system known as the C-Dose Research, according to a July 25 press release. C-Dose enables direct imaging of radiation delivery on a routine basis. It captures both photon and electron beam delivery and can be installed as a fixed ceiling mounted device or on a tripod. It also offers imaging for QA development or human research with a customized visual display and archiving software that matches the workflow of a radiotherapy department.
3. FDA clears Flashback’s blood loss monitor
Flashback Technologies announced in a July 26 press releasethat it has received FDA 510(k) clearance for its CipherOx CRI M1 monitor. The monitor is a handheld device that non invasively calculates and displays heart rate, SpO2 and the compensatory reserve index (CRI). The CipherOx CRI M1 monitor displays CRI as a fuel gauge that rises and falls based on whether a patient is losing volume by bleeding or gaining volume from active fluid resuscitation. The accompanying screen shows the instantaneous CRI value, a 20-minute trend graph, HR and SpO2 values. Flashback Technologies’s new device is battery powered and developed for pre-hospital and hospital settings.
